Magnetic fluid thermochemotherapy of murine tumors
Source abstract
Abstract
Abstract Four series of water-based dextran-ferrite (DF) magnetic fluids (MFs) containing Melphalan (MP) were prepared. Their saturation magnetization ( M s ) was from 0.8 to 7.8 kA/m; specific power absorption rates were 240 W/g Fe. After nine courses of magnetic fluid thermochemotherapy with MP containing DF MF ( M s 7.5 kA/m, pH 6.6, ζ+15 mV) at 44–46 °C for 30 min in an AC magnetic field (0.88 MHz, 9.3 kA/m, 0.3 kW), complete P388 tumor regression was seen in 30% of BDF 1 mice. Furthermore, a life span increase of 180% was achieved.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Cancer, Hypoxia, and Metabolism
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (12)
Show source-provided references
1. Brusentsov · J. Magn. Magn. Mater. · 2001 · 225 · 11310.1016/S0304-8853(00)01238-5 ↗
2. Kuznetsov · J. Magn. Magn. Mater. · 1999 · 194 · 8310.1016/S0304-8853(98)00569-1 ↗
3. Brusentsov · et al. J. Magn. Magn. Mater. · 2002 · 252 · 37810.1016/S0304-8853(02)00634-0 ↗
4. Brusentsov · Mendeleev Chem. J. · 1991 · 36 · 353
5. Brusentsov · Exp. Oncol. · 1990 · 12 · 59
6. Larionov · 1962
7. Jordan · Int. J. Hyperthermia · 1993 · 9 · 5110.3109/02656739309061478 ↗
8. A. Jordan, P. Wust, R. Scholz, et al., Chemotherapy of malignant tumors, in: Häfeli, et al. (Eds.), Scientific and Clinical Application of Magnetic Carriers, Plenum Press, New York, 1997.
9. Brusentsov · Magnetohydrodynamics · 2002 · 38 · 39910.22364/mhd.38.4.7 ↗
10. Brusentsov · Eur. Cells Mat. · 2002 · 3 · 70
11. Syrkin · Exp. Oncol. · 1990 · 12 · 71
12. Häfeli · J. Magn. Magn. Mater. · 1999 · 194 · 7610.1016/S0304-8853(98)00560-5 ↗